[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369980-105":3,"doc-detail-369980-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-survival-analysis-of-t1-stage-breast-cancer-and-nomogram-development-based-on-the-seer-database","A survival analysis of T1 stage breast cancer and nomogram development - based on the SEER database","","Introduction: Breast Cancer (BC) is a widespread non-cutaneous malignancy. T1 stage small tumors are generally viewed as having favorable prognosis, yet treatment and prognostic conclusions remain controversial. Methods: Using SEER data, the study analyzes clinicopathological characteristics and treatment information for T1 patients (2010–2015), then constructs a nomogram from variables selected by multifactorial analysis. Results: 164,906 female records are included; multivariate analysis identifies factors linked to OS and BCSS, with AUC > 0.7. Conclusion: Prognosis differs among T1a, T1b, and T1c, and the nomogram predicts 3-, 5-, and 10-year OS and BCSS.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-survival-analysis-of-t1-stage-breast-cancer-and-nomogram-development-based-on-the-seer-database/369980/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-survival-analysis-of-t1-stage-breast-cancer-and-nomogram-development-based-on-the-seer-database/369980.png","ImageObject",300,407,{"name":42,"@type":43},"kopisore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study on T1 stage breast cancer?","Question",{"text":63,"@type":64},"To perform a survival analysis of T1 stage breast cancer using the SEER database and develop a nomogram to predict outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data source and time period are used to build the cohort and nomogram?",{"text":68,"@type":64},"The cohort uses treatment and clinicopathological information for T1 patients from the SEER database covering 2010–2015.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the study report about prognostic differences among T1a, T1b, and T1c?",{"text":72,"@type":64},"Outcomes show a disparity in prognosis between groups T1a, T1b, and T1c, and the nomogram predicts OS and BCSS reasonably well across 3-, 5-, and 10-year periods.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369980,1790414363,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8",8,"Clinics 80 (2025) 100837  \nContents lists available at ScienceDirect  \nClinics  \njournal [homepage:](homepage: www.elsevier.com/locate/clinsp)[ www.elsevier.com/locate/clinsp](homepage: www.elsevier.com/locate/clinsp)  \n| Original articles\u003Cbr>A survival analysis of T1 stage breast cancer and nomogram development: based on the SEER database |  |  | |\n| --- | --- | --- | --- |\n| Lizhi Teng a,b,c,d , Yuhan Donga,b,c,d , Juntong Du a,b,c,d ,\u003Cbr>Peng Xu a,b,c,d , Weiyang Tao a,b,c,d,* \u003Cbr>a Department of Breast Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China\u003Cbr>b Key Laboratory of Acoustic, Optical and Electromagnetic Diagnosis and Treatment of Cardiovascular Diseases, Heilongjiang, Harbin, China c Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Harbin, Heilongjiang, China\u003Cbr>d NHC Key Laboratory of Cell Transplantation, Heilongjiang, China |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Edited by Jos´e Maria Soares Junior |  | Introduction: Breast Cancer (BC) is a widespread non-cutaneous malignancy. T1 stage of small tumors are generally considered to have a favorable prognosis, but controversy persists regarding their treatment and prognosis.\u003Cbr>Methods: The cohort included clinicopathological characteristics of BC patients along with treatment information from T1 in the Surveillance, Epidemiology and End Results program (SEER) database from 2010‒2015. Construct a nomogram based on the variables identified by the multifactorial analysis results.\u003Cbr>Results: A total of 164,906 female patient records were obtained for enrolment. Patients in the training set of T1 had a 3-, 5-and 10-years of OS for 95.2 %, 90.9 % and 84.4 % as well as a 3-, 5-and 10-years of BCSS for 98.4 %, 97.0 % and 95.4 %. Multivariate analysis found age, race, grade, T-stage, N-stage, chemotherapy, radiation, surgery, Estrogen Receptor (ER) status, Progesterone Receptor (PR) status and Human Epidermal growth factor Receptor-2 (HER2) status to be associated with OS. And age, grade, T-stage, N-stage, chemotherapy, radiation, surgery, diagnosis to treatment, ER-status, PR-status, and HER2-status are associated with BCSS. Independent prognostic risk factors incorporated into the construction of a nomogram. The AUC values for 3-, 5-and 10-years of OS and BCSS were greater than 0.7. The ROC, calibration and DCA curves verified that the nomogram had better predictability and benefits.\u003Cbr>Conclusion: The outcomes demonstrated a disparity in prognosis between groups T1a, T1b, and T1c. The constructed nomogram is able to predict OS and BCSS for 3-, 5- and 10-year periods reasonably well. |  |\n| Keywords:\u003Cbr>Breast cancer T1a, T1b and T1c Nomogram Survival Treatment |  |  |  |\n\nIntroduction  \nBreast Cancer (BC) is the most common non-cutaneous malignant tumor and is the leading cause of cancer deaths in women worldwide.1 According to the newly released GLOBOCAN report, BC (11.7 %) has surpassed lung cancer (11.4 %), with an estimated 2.3 million cases on 2020, and the incidence rate is on the rise.2,3 Given the high prevalence of BC and the enormous threat it poses to women’s health, it has risen tobe a major public health issue that cannot be avoided. Over the past century, early diagnosis of BC has been made possible by the use of mammography programs and the spread of BC screening programs in several countries.4,5 It also leads to considerably better detection of carcinoma in situ and small invasive tumors, especially for T1a-b, which  \naccounted for 23 % of invasive BC \u003C 1 cm diagnosed in 2010.6,7  \nThe updated American Joint Committee on Cancer’s (AJCC) Staging System classified BC based on tumor size. The tumor with a diameter of ≤ 2 cm is described as T1. Within the T1 subgroup, the subgroup of tumors less than or equal to 0.5 cm is called T1a; tumors >0.5 cm and less than or equal to 1 cm are referred to as T1b; and tumors between 1 cm and 2 cm are defined as T1c.8  \nDetection of small tumors is be","cbCaipDiLgYp2gB0","https://ap.wps.com/l/cbCaipDiLgYp2gB0","pdf",2443725,10,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is the main goal of the study on T1 stage breast cancer?\",\"answer\":\"To perform a survival analysis of T1 stage breast cancer using the SEER database and develop a nomogram to predict outcomes.\"},{\"question\":\"Which data source and time period are used to build the cohort and nomogram?\",\"answer\":\"The cohort uses treatment and clinicopathological information for T1 patients from the SEER database covering 2010–2015.\"},{\"question\":\"What does the study report about prognostic differences among T1a, T1b, and T1c?\",\"answer\":\"Outcomes show a disparity in prognosis between groups T1a, T1b, and T1c, and the nomogram predicts OS and BCSS reasonably well across 3-, 5-, and 10-year periods.\"}]","A survival analysis of T1 stage breast cancer and nomogram development - based on the SEER database | PDF",1790185972,25,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/029988a342e1b76733164ee0c65253a4.webp",983,1310,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d50079b59cf449023da3047e719400ae.webp",982,1309,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aacf77c6a9d00b5c8a9c0d73ed473fbc.webp",981,1308,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7841f4c2566256b86d6b5f3f3afe67ba.webp",980,1306,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,152,155,158],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":92,"doc_module":4,"doc_module_name":25,"category_name":156,"show_sort_weight":92,"slug":157},"Lifestyle","lifestyle",{"id":159,"doc_module":4,"doc_module_name":25,"category_name":160,"show_sort_weight":131,"slug":161},19,"General","general"]